These findings showed an increase of AHN in the older AD patients, based mainly on the upregulation of the expression of the neuronal markers DCX, neurogenic differentiation factor TUC4 and PSA-NCAM (Jin et al., 2004b). This evidence concerns the gene DCX and Alzheimer disease.